½ÃÀ庸°í¼­
»óǰÄÚµå
1341987

PCR ±â¼ú ½ÃÀå : µ¿Çâ, ±âȸ, °æÀï ºÐ¼®(2023-2028³â)

PCR Technology Market: Trends, Opportunities and Competitive Analysis [2023-2028]

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Lucintel | ÆäÀÌÁö Á¤º¸: ¿µ¹® 150 Pages | ¹è¼Û¾È³» : 3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

PCR ±â¼ú ½ÃÀå µ¿Çâ ¹× ¿¹Ãø

¼¼°è PCR ±â¼ú ½ÃÀåÀº 2023³âºÎÅÍ 2028³â±îÁö 5.3%ÀÇ CAGR·Î 2028³â±îÁö ¾à 139¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ ½ÃÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀº ¿µÀ¯¾ÆÀÇ °¨¿°¼º ¹× À¯Àü¼º Áúȯ ¹ß»ý·ü Áõ°¡, °í±Þ Áø´Ü ¹æ¹ý¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, °³ÀÎÈ­µÇ°í Á¤È®ÇÑ ÀÇ·á Á¢±Ù ¹æ½Ä¿¡ ´ëÇÑ ¿ä±¸°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¼¼°è PCR ±â¼ú ½ÃÀåÀÇ ¹Ì·¡´Â º´¿ø ¹× Áø´Ü ¼¾ÅÍ, ÇコÄÉ¾î »ê¾÷, ÇÐ°è ¹× Á¤ºÎ ±â°ü, Á¦¾à ¹× »ý¸í°øÇÐ ±â¾÷, ÀÀ¿ë »ê¾÷¿¡¼­ ºñÁö´Ï½º ±âȸ·Î ÀÎÇØ À¯¸ÁÇÑ ½ÃÀåÀÔ´Ï´Ù.

PCR ±â¼ú ½ÃÀå ÀλçÀÌÆ®

  • LucintelÀÇ ¿¹Ãø¿¡ µû¸£¸é, ½Ã¾à ¹× ¼Ò¸ðǰÀº ½ÇÇè½Ç ¹× ¿¬±¸¼Ò¿¡¼­ ÀÌ·¯ÇÑ ¼Ò¸ðǰ¿¡ ´ëÇÑ ÀϰüµÈ ¼ö¿ä, ½Ã¾à ±¸¼ºÀÇ Áõ°¡, ½Å±Ô ¹× °³¼±µÈ PCR È¿¼Ò µµÀÔÀ¸·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È °¡Àå Å« ºÎ¹®À¸·Î ³²À» °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
  • ÀÌ ½ÃÀå¿¡¼­ º´¿ø°ú Áø´Ü ¼¾ÅÍ´Â °¨¿°¼º ÁúȯÀÇ ÀÌȯÀ² Áõ°¡, ¾Ï °ËÁø ¹× Ä¡·á ¹ÝÀÀ ¸ð´ÏÅ͸µÀÇ Áõ°¡, ½Å¼ÓÇϰí Á¤È®ÇÑ Áø´Ü °Ë»ç¸¦ À§ÇÑ ÀÇ·á ÇöÀåÀÇ PCR äÅà Áõ°¡, ƯÈ÷ COVID-19 ÆÒµ¥¹Í ±â°£ µ¿¾È °¢±¤À» ¹ÞÀ¸¸é¼­ °¡Àå Å« ºÎ¹®ÀÌ µÉ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. °¡Àå Å« ºÎ¹®ÀÌ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
  • ºÏ¹Ì´Â Á¤ºÎÀÇ Àû±ØÀûÀÎ ÀÌ´Ï¼ÅÆ¼ºê Áõ°¡, źźÇÑ ÀÇ·á ÀÎÇÁ¶óÀÇ Á¸Àç, Áö¿ª ³» ÀûÀÀ °¡´ÉÇÑ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È °¡Àå Å« Áö¿ªÀ¸·Î ³²¾ÆÀÖÀ» °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

ÀÌ º¸°í¼­´Â ´ÙÀ½°ú °°Àº 11°¡Áö ÁÖ¿ä Áú¹®¿¡ ´ëÇÑ ´äº¯À» ´ã°í ÀÖ½À´Ï´Ù:

  • Q1. ½ÃÀå ºÎ¹® Áß °¡Àå À¯¸ÁÇÏ°í ¼ºÀ强ÀÌ ³ôÀº ±âȸ´Â ¹«¾ùÀΰ¡?
  • Q2. ÇâÈÄ ¼ºÀåÀÌ °¡¼ÓÈ­µÉ ºÎ¹®°ú ±× ÀÌÀ¯´Â?
  • Q3. ÇâÈÄ ¼ºÀåÀÌ °¡¼ÓÈ­µÉ °ÍÀ¸·Î ¿¹»óµÇ´Â Áö¿ª°ú ±× ÀÌÀ¯´Â?
  • Q4. ½ÃÀå ¿ªÇп¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä ¿äÀÎÀº ¹«¾ùÀΰ¡? ½ÃÀåÀÇ ÁÖ¿ä °úÁ¦¿Í ºñÁö´Ï½º ¸®½ºÅ©´Â ¹«¾ùÀΰ¡?
  • Q5. ÀÌ ½ÃÀå¿¡¼­ÀÇ ºñÁö´Ï½º ¸®½ºÅ©¿Í °æÀï À§ÇùÀº ¹«¾ùÀΰ¡?
  • Q6. ÀÌ ½ÃÀåÀÇ »õ·Î¿î Æ®·»µå¿Í ±× ÀÌÀ¯´Â?
  • Q7. ½ÃÀå¿¡¼­ÀÇ °í°´ ¼ö¿ä º¯È­¿¡´Â ¾î¶² °ÍµéÀÌ Àִ°¡?
  • Q8. ÀÌ ½ÃÀåÀÇ »õ·Î¿î ¹ßÀü°ú ±× ¹ßÀüÀ» ÁÖµµÇϰí ÀÖ´Â ±â¾÷Àº?
  • Q9. ÀÌ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷Àº? ÁÖ¿ä ±â¾÷µéÀº »ç¾÷ ¼ºÀåÀ» À§ÇØ ¾î¶² Àü·«Àû ³ë·ÂÀ» ±â¿ïÀ̰í Àִ°¡?
  • Q10. ÀÌ ½ÃÀåÀÇ °æÀï Á¦Ç°¿¡´Â ¾î¶² °ÍµéÀÌ ÀÖÀ¸¸ç, ¼ÒÀç ¹× Á¦Ç° ´ëü¿¡ µû¸¥ ½ÃÀå Á¡À¯À² Ç϶ôÀÇ À§ÇùÀº ¾î´À Á¤µµÀΰ¡?
  • Q11. Áö³­ 5³â°£ ¾î¶² M&A°¡ ÀÌ·ç¾îÁ³°í, ¾÷°è¿¡ ¾î¶² ¿µÇâÀ» ¹ÌÃÆ´Â°¡?

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼¼°èÀÇ PCR ±â¼ú ½ÃÀå : ½ÃÀå ¿ªÇÐ

  • ¼­·Ð, ¹è°æ, ºÐ·ù
  • °ø±Þ¸Á
  • ¾÷°è ¼ºÀå ÃËÁø¿äÀΰú °úÁ¦

Á¦3Àå 2017³âºÎÅÍ 2028³â±îÁö ½ÃÀå µ¿Çâ°ú ¿¹Ãø ºÐ¼®

  • °Å½Ã°æÁ¦ µ¿Çâ(2017-2022³â)°ú ¿¹Ãø(2023-2028³â)
  • ¼¼°èÀÇ PCR ±â¼ú ½ÃÀå µ¿Çâ(2017-2022³â)°ú ¿¹Ãø(2023-2028³â)
  • Á¦Ç°º° ¼¼°èÀÇ PCR ±â¼ú ½ÃÀå
    • ¼ÒÇÁÆ®¿þ¾î¿Í ¼­ºñ½º
    • ±â±â
    • ½Ã¾à°ú ¼Ò¸ðǰ
  • ±â¼úº° ¼¼°èÀÇ PCR ±â¼ú ½ÃÀå
    • ±âÁ¸ PCR
    • ½Ç½Ã°£ PCR
    • µðÁöÅÐ PCR
    • ¿ªÀü»ç PCR
    • ÇÖ ½ºÅ¸Æ® PCR
    • ¸ÖƼÇ÷º½º PCR
    • ±âŸ
  • ÃÖÁ¾ ÀÌ¿ë »ê¾÷º° ¼¼°è PCR ±â¼ú ½ÃÀå
    • º´¿ø°ú Áø´Ü ¼¾ÅÍ
    • ÇコÄÉ¾î »ê¾÷
    • Çмú±â°ü ¹× Á¤ºÎ±â°ü
    • ÆÄ¸¶ ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷
    • ÀÀ¿ë »ê¾÷
    • ±âŸ

Á¦4Àå 2017³âºÎÅÍ 2028³â±îÁö Áö¿ªº° ½ÃÀå µ¿Çâ°ú ¿¹Ãø ºÐ¼®

  • Áö¿ªº° ¼¼°èÀÇ PCR ±â¼ú ½ÃÀå
  • ºÏ¹ÌÀÇ PCR ±â¼ú ½ÃÀå
  • À¯·´ÀÇ PCR ±â¼ú ½ÃÀå
  • ¾Æ½Ã¾ÆÅÂÆò¾ç PCR ±â¼ú ½ÃÀå
  • ±âŸ Áö¿ª PCR ±â¼ú ½ÃÀå

Á¦5Àå °æÀï ºÐ¼®

  • Á¦Ç° Æ÷Æ®Æú¸®¿À ºÐ¼®
  • ¿î¿µ»ó ÅëÇÕ
  • Porter's Five Forces ºÐ¼®

Á¦6Àå ¼ºÀå ±âȸ¿Í Àü·«Àû ºÐ¼®

  • ¼ºÀå ±âȸ ºÐ¼®
    • Á¦Ç°º° PCR ±â¼ú ½ÃÀå ¼ºÀå ±âȸ
    • ±â¼úº° ¼¼°èÀÇ PCR ±â¼ú ½ÃÀå ¼ºÀå ±âȸ
    • ÃÖÁ¾ ÀÌ¿ë »ê¾÷º° ¼¼°è PCR ±â¼ú ½ÃÀå ¼ºÀå ±âȸ
    • Áö¿ªº° ¼¼°èÀÇ PCR ±â¼ú ½ÃÀå ¼ºÀå ±âȸ
  • ¼¼°èÀÇ PCR ±â¼ú ½ÃÀåÀÇ »õ·Î¿î µ¿Çâ
  • Àü·«Àû ºÐ¼®
    • ½ÅÁ¦Ç°ÀÇ °³¹ß
    • ¼¼°èÀÇ PCR ±â¼ú ½ÃÀå ´É·Â È®´ë
    • ¼¼°èÀÇ PCR ±â¼ú ½ÃÀå ÇÕº´, Àμö, ÇÕÀÛÅõÀÚ
    • ÀÎÁõ°ú ¶óÀ̼±½Ì

Á¦7Àå À¯·Â ±â¾÷ÀÇ ±â¾÷ °³¿ä

  • Thermo Fisher Scientific
  • Promega Corporation
  • Becton Dickinson and Company
  • Agilent Technologies
  • F. Hoffman-La Roche
  • Bio-Rad Laboratories
  • Abbott Laboratorie
  • Fluidigm Corporation
  • Danaher Corporation
  • Takara Bio
ksm 23.10.24

PCR Technology Market Trends and Forecast

The future of the global PCR technology market looks promising with opportunities in the hospital and diagnostic center, healthcare industry, academia and government organization, pharma-biotech company, and applied industries. The global PCR technology market is expected to reach an estimated $13.9 billion by 2028 with a CAGR of 5.3% from 2023 to 2028. The major drivers for this market are rising occurrences of infectious diseases and genetic disorders in infants, growing need for sophisticated diagnostic methods, and increasing requirement for personalized and precise medical approaches.

A more than 150-page report is developed to help in your business decisions.

PCR Technology Market by Segment

The study includes trends and forecast for the global PCR technology market by product, technology, and end use industry, and region as follows:

PCR Technology Market by Product [Shipment Analysis by Value from 2017 to 2028]:

  • Software and Services
  • Instruments
  • Reagents & Consumables

PCR Technology Market by Technology [Shipment Analysis by Value from 2017 to 2028]:

  • Conventional PCR
  • Real-time PCR
  • Digital PCR
  • Reverse Transcription PCR
  • Hot-Start PCR
  • Multiplex PCR
  • Others

PCR Technology Market by End Use Industry [Shipment Analysis by Value from 2017 to 2028]:

  • Hospitals and Diagnostic Centers
  • Healthcare Industry
  • Academic and Government Organizations
  • Pharma-Biotech Companies
  • Applied Industries
  • Others

PCR Technology Market by Region [Shipment Analysis by Value from 2017 to 2028]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of PCR Technology Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, PCR technology companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the PCR technology companies profiled in this report includes-

  • Thermo Fisher Scientific
  • Promega Corporation
  • Becton Dickinson and Company
  • Agilent Technologies
  • F. Hoffman-La Roche
  • Bio-Rad Laboratories
  • Abbott Laboratorie
  • Fluidigm Corporation
  • Danaher Corporation
  • Takara Bio

PCR Technology Market Insights

  • Lucintel forecasts that reagents and consumables will remain the largest segment over the forecast period due to the consistent demand for these supplies in laboratories and research institutes, as well as increasing advancements in reagent compositions, and the introduction of novel and improved PCR enzymes.
  • Within this market, hospitals and diagnostic centers will remain the largest segment due to increasing incidence of infectious diseases, rising screening for cancer and monitoring treatment responses, and growing adoption of PCR in medical settings for rapid and accurate diagnostic examinations, especially highlighted during the COVID-19 pandemic.
  • North America will remain the largest region over the forecast period due to increasing positive government initiatives, existence of robust healthcare infrastructure, and adaptable regulatory frameworks within the region.

Features of the Global PCR technology Market

  • Market Size Estimates: PCR technology market size estimation in terms of value ($B).
  • Trend and Forecast Analysis: Market trends (2017 to 2022) and forecast (2023 to 2028) by various segments and regions.
  • Segmentation Analysis: PCR technology market size by various segments, such as by product, technology, end use industry, and region in terms of value ($B).
  • Regional Analysis: PCR technology market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different products, technologies, end use industries, and regions for the PCR technology market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the PCR technology market.
  • Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

    Q.1. What is the PCR technology market size?

  • Answer: The global PCR technology market is expected to reach an estimated $13.9 billion by 2028.

    Q.2. What is the growth forecast for PCR technology market?

  • Answer: The global PCR technology market is expected to grow with a CAGR of 5.3% from 2023 to 2028.

    Q.3. What are the major drivers influencing the growth of the PCR technology market?

  • Answer: The major drivers for this market are rising occurrences of infectious diseases and genetic disorders in infants, growing need for sophisticated diagnostic methods, and increasing requirement for personalized and precise medical approaches.

    Q4. What are the major segments for PCR technology market?

  • Answer: The future of the global PCR technology market looks promising with opportunities in the hospital and diagnostic center, healthcare industry, academia and government organization, pharma-biotech company, and applied industries.

    Q5. Who are the key PCR technology companies?

  • Answer: Some of the key PCR technology companies are as follows:
    • Thermo Fisher Scientific
    • Promega Corporation
    • Becton Dickinson and Company
    • Agilent Technologies
    • F. Hoffman-La Roche
    • Bio-Rad Laboratories
    • Abbott Laboratorie
    • Fluidigm Corporation
    • Danaher Corporation
    • Takara Bio

    Q6. Which PCR technology market segment will be the largest in future?

  • Answer: Lucintel forecasts that reagents and consumables will remain the largest segment over the forecast period due to the consistent demand for these supplies in laboratories and research institutes as well as increasing advancements in reagent compositions, and the introduction of novel and improved PCR enzymes.

    Q7. In PCR technology market, which region is expected to be the largest in next 5 years?

  • Answer: North America will remain the largest region over the forecast period due to increasing positive government initiatives, existence of robust healthcare infrastructure, and adaptable regulatory frameworks within the region.

    Q.8. Do we receive customization in this report?

  • Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the global PCR technology market by product (software and services, instruments, and reagents & consumables), technology (conventional PCR, real-time PCR, digital PCR, reverse transcription PCR, hot-start PCR, multiplex PCR, and others), end use industry (hospitals and diagnostic centers, healthcare industry, academia and government organizations, pharma-biotech companies, applied industries, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last five years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global PCR Technology Market: Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2017 to 2028

  • 3.1: Macroeconomic Trends (2017-2022) and Forecast (2023-2028)
  • 3.2: Global PCR Technology Market Trends (2017-2022) and Forecast (2023-2028)
  • 3.3: Global PCR Technology Market by Product
    • 3.3.1: Software and Services
    • 3.3.2: Instruments
    • 3.3.3: Reagents & consumables
  • 3.4: Global PCR Technology Market by Technology
    • 3.4.1: Conventional PCR
    • 3.4.2: Real-time PCR
    • 3.4.3: Digital PCR
    • 3.4.4: Reverse Transcription PCR
    • 3.4.5: Hot-Start PCR
    • 3.4.6: Multiplex PCR
    • 3.4.7: Others
  • 3.5: Global PCR Technology Market by End Use Industry
    • 3.5.1: Hospitals and Diagnostic Centers
    • 3.5.2: Healthcare Industry
    • 3.5.3: Academic and Government Organizations
    • 3.5.4: Pharma-Biotech Companies
    • 3.5.5: Applied Industries
    • 3.5.6: Others

4. Market Trends and Forecast Analysis by Region from 2017 to 2028

  • 4.1: Global PCR Technology Market by Region
  • 4.2: North American PCR Technology Market
    • 4.2.1: North American PCR Technology Market by Product: Software and Services, Instruments, and Reagents & Consumables
    • 4.2.2: North American PCR Technology Market by End Use Industry: Hospitals and Diagnostic Centers, Healthcare Industry, Academic and Government Organizations, Pharma-Biotech Companies, Applied Industries, and Others
  • 4.3: European PCR Technology Market
    • 4.3.1: European PCR Technology Market by Product: Software and Services, Instruments, and Reagents & Consumables
    • 4.3.2: European PCR Technology Market by End Use Industry: Hospitals and Diagnostic Centers, Healthcare Industry, Academic and Government Organizations, Pharma-Biotech Companies, Applied Industries, and Others
  • 4.4: APAC PCR Technology Market
    • 4.4.1: APAC PCR Technology Market by Product: Software and Services, Instruments, and Reagents & Consumables
    • 4.4.2: APAC PCR Technology Market by End Use Industry: Hospitals and Diagnostic Centers, Healthcare Industry, Academic and Government Organizations, Pharma-Biotech Companies, Applied Industries, and Others
  • 4.5: ROW PCR Technology Market
    • 4.5.1: ROW PCR Technology Market by Product: Software and Services, Instruments, and Reagents & Consumables
    • 4.5.2: ROW PCR Technology Market by End Use Industry: Hospitals and Diagnostic Centers, Healthcare Industry, Academic and Government Organizations, Pharma-Biotech Companies, Applied Industries, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the PCR Technology Market by Product
    • 6.1.2: Growth Opportunities for the Global PCR Technology Market by Technology
    • 6.1.3: Growth Opportunities for the Global PCR Technology Market by End Use Industry
    • 6.1.4: Growth Opportunities for the Global PCR Technology Market by Region
  • 6.2: Emerging Trends in the Global PCR Technology Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global PCR Technology Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global PCR Technology Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Thermo Fisher Scientific
  • 7.2: Promega Corporation
  • 7.3: Becton Dickinson and Company
  • 7.4: Agilent Technologies
  • 7.5: F. Hoffman-La Roche
  • 7.6: Bio-Rad Laboratories
  • 7.7: Abbott Laboratorie
  • 7.8: Fluidigm Corporation
  • 7.9: Danaher Corporation
  • 7.10: Takara Bio
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦